SR

Shreya Rai Menala

Active Director Director DIN 10472925
DIN 10472925 First appointment Jan 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Shreya Rai Menala

Data last updated:

Shreya Rai Menala is a Director at Eukairos Private Limited (since 2024) and Director at Anthrapi Private Limited (since 2024).

DIN 10472925
Primary Designation Director
First Appointment 19 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eukairos Private Limited U62013KA2024PTC183852
Director22 Jan 20242024Active
Anthrapi Private Limited U78300KA2024PTC183715
Director19 Jan 20242024Active

Board colleagues of Shreya Rai Menala

NameDINCompanyDesignation
Shalini Lal09083515Eukairos Private Limited , Anthrapi Private LimitedDirector

Directorship timeline

Open interactive timeline →
Anthrapi Private Limited
Eukairos Private Limited
Premium access

Shareholding and investment profile for Shreya Rai Menala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shreya Rai Menala

Shreya Rai Menala currently holds 2 directorships: Eukairos Private Limited (Director, since 22 Jan 2024); Anthrapi Private Limited (Director, since 19 Jan 2024).

Shreya Rai Menala was first appointed on 19 Jan 2024 as Director at Anthrapi Private Limited.

The current boards of Shreya Rai Menala's companies include Shalini Lal (Eukairos Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available